92 related articles for article (PubMed ID: 24470447)
1. Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen.
Haag S; Schneider N; Mason DE; Tuncel J; Andersson IE; Peters EC; Burkhardt H; Holmdahl R
Arthritis Rheumatol; 2014 Jun; 66(6):1440-9. PubMed ID: 24470447
[TBL] [Abstract][Full Text] [Related]
2. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis.
Kinloch A; Tatzer V; Wait R; Peston D; Lundberg K; Donatien P; Moyes D; Taylor PC; Venables PJ
Arthritis Res Ther; 2005; 7(6):R1421-9. PubMed ID: 16277695
[TBL] [Abstract][Full Text] [Related]
3. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
Harre U; Georgess D; Bang H; Bozec A; Axmann R; Ossipova E; Jakobsson PJ; Baum W; Nimmerjahn F; Szarka E; Sarmay G; Krumbholz G; Neumann E; Toes R; Scherer HU; Catrina AI; Klareskog L; Jurdic P; Schett G
J Clin Invest; 2012 May; 122(5):1791-802. PubMed ID: 22505457
[TBL] [Abstract][Full Text] [Related]
4. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis.
van Venrooij WJ; Pruijn GJ
Arthritis Res; 2000; 2(4):249-51. PubMed ID: 11094435
[TBL] [Abstract][Full Text] [Related]
5. Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.
Travers TS; Harlow L; Rosas IO; Gochuico BR; Mikuls TR; Bhattacharya SK; Camacho CJ; Ascherman DP
J Immunol; 2016 Sep; 197(5):1926-36. PubMed ID: 27448590
[TBL] [Abstract][Full Text] [Related]
6. Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.
Nandakumar KS
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495570
[TBL] [Abstract][Full Text] [Related]
7. Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.
Muller S; Radic M
Clin Rev Allergy Immunol; 2015 Oct; 49(2):232-9. PubMed ID: 25355199
[TBL] [Abstract][Full Text] [Related]
8. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
[TBL] [Abstract][Full Text] [Related]
9. Editorial: citrullination, and carbamylation, and malondialdehyde-acetaldehyde! Oh my! Entering the forest of autoantigen modifications in rheumatoid arthritis.
Darrah E; Andrade F
Arthritis Rheumatol; 2015 Mar; 67(3):604-8. PubMed ID: 25469991
[No Abstract] [Full Text] [Related]
10. The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis.
Hecht C; Schett G; Finzel S
Ann Rheum Dis; 2015 Jan; 74(1):e4. PubMed ID: 25326218
[No Abstract] [Full Text] [Related]
11. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis.
Gully N; Bright R; Marino V; Marchant C; Cantley M; Haynes D; Butler C; Dashper S; Reynolds E; Bartold M
PLoS One; 2014; 9(6):e100838. PubMed ID: 24959715
[TBL] [Abstract][Full Text] [Related]
13. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
[TBL] [Abstract][Full Text] [Related]
14. Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides.
Tutturen AE; Fleckenstein B; de Souza GA
J Proteome Res; 2014 Jun; 13(6):2867-73. PubMed ID: 24724574
[TBL] [Abstract][Full Text] [Related]
15. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
Kissel T; Reijm S; Slot LM; Cavallari M; Wortel CM; Vergroesen RD; Stoeken-Rijsbergen G; Kwekkeboom JC; Kampstra A; Levarht E; Drijfhout JW; Bang H; Bonger KM; Janssen G; van Veelen PA; Huizinga T; Scherer HU; Reth M; Toes R
Ann Rheum Dis; 2020 Apr; 79(4):472-480. PubMed ID: 32041746
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies.
Ge C; Xu B; Liang B; Lönnblom E; Lundström SL; Zubarev RA; Ayoglu B; Nilsson P; Skogh T; Kastbom A; Malmström V; Klareskog L; Toes REM; Rispens T; Dobritzsch D; Holmdahl R
Arthritis Rheumatol; 2019 Feb; 71(2):210-221. PubMed ID: 30152126
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis.
Nandakumar KS; Fang Q; Wingbro Ågren I; Bejmo ZF
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958864
[TBL] [Abstract][Full Text] [Related]
18. Significance of Type II Collagen Posttranslational Modifications: From Autoantigenesis to Improved Diagnosis and Treatment of Rheumatoid Arthritis.
Batsalova T; Dzhambazov B
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373030
[TBL] [Abstract][Full Text] [Related]
19. Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients.
Xu M; Du R; Xing W; Chen X; Wan J; Wang S; Xiong L; Nandakumar KS; Holmdahl R; Geng H
Front Immunol; 2023; 14():1084283. PubMed ID: 36761728
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-related citrullination of matrisome proteins in human cancer.
Rappu P; Suwal U; Siljamäki E; Heino J
Front Oncol; 2022; 12():1035188. PubMed ID: 36531007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
